External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study
- PMID: 36355199
- DOI: 10.1007/s00330-022-09204-5
External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study
Abstract
Objectives: The aim of this study was two-fold: (1) to develop and externally validate a multiparameter MR-based machine learning model to predict the pathological complete response (pCR) in locally advanced rectal cancer (LARC) patients after neoadjuvant chemoradiotherapy (nCRT), and (2) to compare different classifiers' discriminative performance for pCR prediction.
Methods: This retrospective study includes 151 LARC patients divided into internal (centre A, n = 100) and external validation set (centre B, n = 51). The clinical and MR radiomics features were derived to construct clinical, radiomics, and clinical-radiomics model. Random forest (RF), support vector machine (SVM), logistic regression (LR), K-nearest neighbor (KNN), naive Bayes (NB), and extreme gradient boosting (XGBoost) were used as classifiers. The predictive performance was assessed using the receiver operating characteristic (ROC) curve.
Results: Eleven radiomics and four clinical features were chosen as pCR-related signatures. In the radiomics model, the RF algorithm achieved 74.0% accuracy (an AUC of 0.863) and 84.4% (an AUC of 0.829) in the internal and external validation sets. In the clinical-radiomics model, RF algorithm exhibited high and stable predictive performance in the internal and external validation datasets with an AUC of 0.906 (87.3% sensitivity, 73.7% specificity, 76.0% accuracy) and 0.872 (77.3% sensitivity, 88.2% specificity, 86.3% accuracy), respectively. RF showed a better predictive performance than the other classifiers in the external validation datasets of three models.
Conclusions: The multiparametric clinical-radiomics model combined with RF algorithm is optimal for predicting pCR in the internal and external sets, and might help improve clinical stratifying management of LARC patients.
Key points: • A two-centre study showed that radiomics analysis of pre- and post-nCRT multiparameter MR images could predict pCR in patients with LARC. • The combined model was superior to the clinical and radiomics model in predicting pCR in locally advanced rectal cancer. • The RF classifier performed best in the current study.
Keywords: Machine learning; Magnetic resonance imaging; Neoadjuvant therapy; Rectal neoplasm.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
MRI radiomics combined with delta-radiomics model for predicting pathological complete response in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy: A multi-institutional study.Appl Radiat Isot. 2025 Aug;222:111842. doi: 10.1016/j.apradiso.2025.111842. Epub 2025 Apr 12. Appl Radiat Isot. 2025. PMID: 40273481
-
Endorectal ultrasound radiomics in locally advanced rectal cancer patients: despeckling and radiotherapy response prediction using machine learning.Abdom Radiol (NY). 2022 Nov;47(11):3645-3659. doi: 10.1007/s00261-022-03625-y. Epub 2022 Aug 11. Abdom Radiol (NY). 2022. PMID: 35951085
-
Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning.Eur J Surg Oncol. 2024 Dec;50(12):108738. doi: 10.1016/j.ejso.2024.108738. Epub 2024 Oct 6. Eur J Surg Oncol. 2024. PMID: 39395242
-
Significance of MRI-based radiomics in predicting pathological complete response to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A narrative review.Cancer Radiother. 2024 Aug;28(4):390-401. doi: 10.1016/j.canrad.2024.04.003. Epub 2024 Aug 22. Cancer Radiother. 2024. PMID: 39174361 Review.
-
MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis.Front Oncol. 2025 Mar 10;15:1550838. doi: 10.3389/fonc.2025.1550838. eCollection 2025. Front Oncol. 2025. PMID: 40129922 Free PMC article.
Cited by
-
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?Cancers (Basel). 2023 Jan 9;15(2):432. doi: 10.3390/cancers15020432. Cancers (Basel). 2023. PMID: 36672381 Free PMC article. Review.
-
Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis.Br J Radiol. 2024 Jun 18;97(1159):1243-1254. doi: 10.1093/bjr/tqae098. Br J Radiol. 2024. PMID: 38730550 Free PMC article.
-
Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.Radiol Med. 2024 Apr;129(4):598-614. doi: 10.1007/s11547-024-01796-w. Epub 2024 Mar 21. Radiol Med. 2024. PMID: 38512622
-
Artificial Intelligence and Rectal Cancer: Beyond Images.Cancers (Basel). 2025 Jul 3;17(13):2235. doi: 10.3390/cancers17132235. Cancers (Basel). 2025. PMID: 40647531 Free PMC article. Review.
-
Quantitative analysis of contrast-enhanced ultrasound in neoadjuvant treatment of locally advanced rectal cancer: a retrospective study.Front Oncol. 2024 Jan 23;13:1340060. doi: 10.3389/fonc.2023.1340060. eCollection 2023. Front Oncol. 2024. PMID: 38322290 Free PMC article.
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources